Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.

Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood. 1999 Jul 15; 94(2):803-7.

View in: PubMed

subject areas

Alleles
Antineoplastic Agents
Chromosomes, Human, Pair 5
Chromosomes, Human, Pair 7
Codon
DNA Mutational Analysis
Female
Gene Frequency
Genotype
Humans
Karyotyping
Leukemia, Myeloid
Male
Myelodysplastic Syndromes
NAD(P)H Dehydrogenase (Quinone)
Neoplasm Proteins
Neoplasms, Radiation-Induced
Neoplasms, Second Primary
Point Mutation
Polymerase Chain Reaction
Polymorphism, Genetic
Radiotherapy

authors with profiles

Richard A. Larson